Cargando…
The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits
In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127493/ https://www.ncbi.nlm.nih.gov/pubmed/27898675 http://dx.doi.org/10.1371/journal.pmed.1002182 |